FMC Corporation (FMC)
NYSEMaterialsAgricultural InputsSnapshot 2026-09-09
$12.29-4.06%
Close 2026-09-09 · 1-day change
NYSEMaterialsAgricultural InputsSnapshot 2026-09-09
Broken: Primary pillar broken — EPS near $1.76 per share: FY26 EPS guidance mid $1.34 vs target $1.63.
FMC aims to cut $1 billion in debt to improve finances. Sales are expected near $3.7 billion in 2026. The company plans to earn about $1.76 per share in 2026. New partnerships and product approvals support future growth.
FMC is still losing money and faces volatile management. Debt concerns could hurt financial strength. Sales fell 4% last quarter and profit remains negative.
The market expects about 8% revenue growth in the next year. Our fair value is near $36, reflecting cautious optimism. We see risk from ongoing losses and debt pressure.
Breaks if: Buyback program is canceled or delayed significantly
Breaks if: Debt reduction target is not met by Q1 2026
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a turnaround scenario with a focus on improving operational execution. The current thesis state indicates a watchful approach due to recent weak financial performance and high risk factors.
The market seems to have priced in FMC's fragility, as indicated by its valuation being cheap compared to peers. There is an expectations gap, suggesting that the market anticipates some challenges ahead but not the full extent of the company's issues.
FMC's fundamentals may struggle in the near term due to weak recent performance and volatile management. However, there are signs of progress in new active ingredients, which could help stabilize growth over the multi-year horizon.
The thesis hinges on FMC's ability to strengthen its balance sheet, improve execution on strategic options, and capitalize on favorable sector conditions. Key triggers include potential guidance increases and sector momentum from peers.
The most important moves since the prior daily snapshot.
Mixed, the news cuts both ways. The latest earnings beat supports the read. However, the company cut its outlook, which threatens the read. This indicates potential difficulties in executing its share buyback program.
as of 2026-09-09
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Execute targeted debt reduction of approximately $1 billion through asset sales, licensing agreements, and equity investment to improve financial flexibility.
Stated as a priority in 3 of last 3 quarters. FMC announced targeted debt reduction of approximately $1 billion through asset sales, licensing agreements, and a $400 million equity investment from Tessenderlo Group. This aligns with the company's operational focus and financial actions taken, indicating delivery on this priority.
“FMC is focused on executing its 2026 operational priorities, including strengthening the balance sheet by paying down $1 billion in debt through asset sales and licensing agreements.”
“FMC announced key components of its targeted approximately $1 billion of proceeds to be used for debt reduction.”
“FMC is making strong progress on its 2026 operational priorities, which are strengthening the balance sheet through targeted debt reduction of approximately $1 billion.”
Breaks if: EPS falls below $1.63 in FY26
Breaks if: Revenue falls below $3.6 billion in FY26
Overall, FMC's outlook remains uncertain, with several factors influencing its trajectory. Not investment advice.